BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 28074614)

  • 21. Non-ocular melanomas in cats: a retrospective study of 30 cases.
    Chamel G; Abadie J; Albaric O; Labrut S; Ponce F; Ibisch C
    J Feline Med Surg; 2017 Apr; 19(4):351-357. PubMed ID: 26767979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Malignant melanoma in two cats].
    Schiller I; Spiess B; Pospischil A
    Schweiz Arch Tierheilkd; 1995; 137(2):50-3. PubMed ID: 7777836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological characteristics and mutation profiling in primary cutaneous melanoma.
    Yaman B; Akalin T; Kandiloğlu G
    Am J Dermatopathol; 2015 May; 37(5):389-97. PubMed ID: 25357015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of monocarboxylate transporter 1 in oral and ocular canine melanocytic tumors.
    Shimoyama Y; Akihara Y; Kirat D; Iwano H; Hirayama K; Kagawa Y; Ohmachi T; Matsuda K; Okamoto M; Kadosawa T; Yokota H; Taniyama H
    Vet Pathol; 2007 Jul; 44(4):449-57. PubMed ID: 17606506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
    Larsen AC
    Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C-Kit SCF receptor (CD117) expression and KIT gene mutation in conjunctival pigmented lesions.
    Alessandrini L; Parrozzani R; Bertorelle R; Valentini E; Candiotto C; Giacomelli L; Midena E; Blandamura S
    Acta Ophthalmol; 2013 Dec; 91(8):e641-5. PubMed ID: 23742652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of topical ocular administration of high doses of human recombinant interferon alpha-2b and feline recombinant interferon omega on naturally occurring viral keratoconjunctivitis in cats.
    Slack JM; Stiles J; Leutenegger CM; Moore GE; Pogranichniy RM
    Am J Vet Res; 2013 Feb; 74(2):281-9. PubMed ID: 23363355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.
    Lázár V; Ecsedi S; Vízkeleti L; Rákosy Z; Boross G; Szappanos B; Bégány A; Emri G; Adány R; Balázs M
    Melanoma Res; 2012 Jun; 22(3):202-14. PubMed ID: 22456166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.
    Reifenberger J; Knobbe CB; Sterzinger AA; Blaschke B; Schulte KW; Ruzicka T; Reifenberger G
    Int J Cancer; 2004 Apr; 109(3):377-84. PubMed ID: 14961576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exon 15 BRAF mutations are uncommon in canine oral malignant melanomas.
    Shelly S; Chien MB; Yip B; Kent MS; Theon AP; McCallan JL; London CA
    Mamm Genome; 2005 Mar; 16(3):211-7. PubMed ID: 15834638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melanocytic Ophthalmic Neoplasms of the Domestic Veterinary Species: A Review.
    Wang AL; Kern T
    Top Companion Anim Med; 2015 Dec; 30(4):148-57. PubMed ID: 27154598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Classification of feline intraocular neoplasms based on morphology, histochemical staining, and immunohistochemical labeling.
    Grahn BH; Peiffer RL; Cullen CL; Haines DM
    Vet Ophthalmol; 2006; 9(6):395-403. PubMed ID: 17076872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition.
    Antonescu CR; Busam KJ; Francone TD; Wong GC; Guo T; Agaram NP; Besmer P; Jungbluth A; Gimbel M; Chen CT; Veach D; Clarkson BD; Paty PB; Weiser MR
    Int J Cancer; 2007 Jul; 121(2):257-64. PubMed ID: 17372901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GNAQ and PMS1 Mutations Associated with Uveal Melanoma, Ocular Surface Melanosis, and Nevus of Ota.
    Toomey CB; Fraser K; Thorson JA; Goldbaum MH; Lin JH
    Ocul Oncol Pathol; 2019 Jun; 5(4):267-272. PubMed ID: 31367589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KIT pathway alterations in mucosal melanomas of the vulva and other sites.
    Omholt K; Grafström E; Kanter-Lewensohn L; Hansson J; Ragnarsson-Olding BK
    Clin Cancer Res; 2011 Jun; 17(12):3933-42. PubMed ID: 21680547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of AP-2alpha, c-kit, and cleaved caspase-6 and -3 in naevi and malignant melanomas of the skin. A possible role for caspases in melanoma progression?
    Woenckhaus C; Giebel J; Failing K; Fenic I; Dittberner T; Poetsch M
    J Pathol; 2003 Oct; 201(2):278-87. PubMed ID: 14517845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Excision of a feline limbal melanoma and use of nictitans cartilage to repair the resulting corneoscleral defect.
    Kanai K; Kanemaki N; Matsuo S; Ichikawa Y; Okujima H; Wada Y
    Vet Ophthalmol; 2006; 9(4):255-8. PubMed ID: 16771762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutation scanning of BRAF, NRAS, KIT, and GNAQ/GNA11 in oral mucosal melanoma: a study of 57 cases.
    Lyu J; Wu Y; Li C; Wang R; Song H; Ren G; Guo W
    J Oral Pathol Med; 2016 Apr; 45(4):295-301. PubMed ID: 26399561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutation analysis of metastatic melanomas in the central nervous system: results of a panel of 5 genes in 48 cases.
    Gamsizkan M; Yilmaz I; Simsek HA; Onguru O; Griffin A; Tihan T
    Clin Neuropathol; 2016; 35(4):178-85. PubMed ID: 27117140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Telomerase activity with concurrent loss of cell cycle regulation in feline post-traumatic ocular sarcomas.
    Carter RT; Giudice C; Dubielzig RR; Colitz CM
    J Comp Pathol; 2005 Nov; 133(4):235-45. PubMed ID: 16154137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.